Have a feature idea you'd love to see implemented? Let us know!
Back to NVCR overview

NVCR NovoCure PE ratio, current and historical analysis

The current PE ratio of NVCR can't be determined, as the TTM EPS of -$1.39 is negative. The most recent PE ratio recorded for NovoCure was 1101.5 in March 2021.

NVCR PE ratio history

How has NVCR's PE ratio performed in the past

Over the last nine years, the average PE ratio of NovoCure has been 609.94. Over the past nine years, NVCR's PE ratio was at its highest in the Mar 2021 quarter at 1,101.5, with a price of $132.18 and an EPS of $0.12. The Sep 2016 quarter recorded the bottom point at 6.83, with a price of $8.54 and an EPS of $1.25.

Average
609.94
Median
614.98
Minimum
6.83
Maximum
1,101.5

NovoCure PE ratio by year

Year PE ratio Change
2023 N/A N/A
2022 N/A N/A
2021 N/A N/A
2020 865.2 N/A
2019 N/A N/A
2018 N/A N/A
2017 N/A N/A
2016 N/A N/A
2015 N/A N/A
2014 N/A N/A

NVCR average PE ratio chart

What is the average PE ratio of NVCR for the past years
3-year avg
N/A
5-year avg
730.56
10-year avg
N/A
15-year avg
N/A

NVCR PE vs peers

What is NVCR's PE ratio compared to its peers
Stock name PE ratio Market cap
NBIX Neurocrine Biosciences Inc 35.08 $13.71B
NVAX Novavax Inc N/A $1.39B
NVCR NovoCure Ltd N/A $3.33B

Frequently asked questions

What is NovoCure's PE ratio?

The current price to earnings ratio of NVCR can't be calculated, as its EPS of -$1.39 is negative.

What is the 5-year average PE ratio for NovoCure (NVCR)?

Over the last 5 years, the average price to earnings ratio for NVCR stock is 730.56.

What is the highest PE ratio for NVCR?

The highest quarterly PE ratio in the last nine years has been 1,101.5 and it was in the Mar 2021 quarter.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.